Light Mode
$171.67 ↓ -0.11 (-0.06%) Trading Down from the previous close of $171.78, $6.32 below the day’s high of $177.99
+54.25 (+46.16%) / 6M
Momentum, market sentiment, and recent alerts
A reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +17.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.